The global spine biologics market size is expected to reach
USD 2.5 billion by 2026, according to a new report by Grand View Research,
Inc., registering a 4.2% CAGR over the forecast period. The market is primarily
driven by increasing incidence of spinal injuries. Prevalence of spinal
deformities has been on a rise in developed and underdeveloped countries and
this has resulted in an increase in the number of surgeries being carried. This
has had a positive impact on the market for spine biologics.
Apart from this, growing awareness about
numerous advantages of biologics in spine fusion surgeries, such as minimal
postoperative time and ability to activate cellular growth, has also propelled
the market. Biomaterials and bone graft substitutes are being adopted as the
choice of treatment for spinal deformities. Increasing percentage of the
elderly population suffering from spinal disorders and rising adoption of these
products as a treatment method is anticipated to boost the market for spine
biologics over the forecast period.
The geriatric population is more prone to
spondylolisthesis and degeneration of disc. This, coupled with increasing
number of trauma cases due to road accidents and sports injuries, is driving
demand for spine biologics. According to the Open Access Journal for Minimally
Invasive Surgery (MIS) published in 2018, minimally invasive techniques are
being adopted for the treatment of a wide range of spine pathologies.
Approximately 400,000 cases are performed in the U.S. annually and spine fusion
has turned out to be one of the most commonly performed and well-established
treatment options for spine trauma, degenerative disorders, tumors, and
structural abnormalities.
Browse full research report on Spine
Biologics Market:
https://www.grandviewresearch.com/industry-analysis/spine-biologics-market
Further key
findings from the report suggest:
- Many clinicians
consider spinal allografts as the gold standard for spinal fusion. The use
of biologics influences surgical outcomes as it helps in improving fusion
rates and reducing pain. This driven the segment to account for the
dominant revenue share
- Hospitals held the
leading share in terms of end use in 2018 owing to availability of highly
skilled professionals and increasing number of spine surgeries performed.
Ambulatory Surgery Centers (ASC), on the other hand, are anticipated to
witness lucrative growth over the forecast period
- North America
captured the largest share in the market in 2018, owing to presence of
well-established healthcare infrastructure, high awareness among surgeons
pertinent to bone graft procedures, and availability of favorable
reimbursement policies
- Asia Pacific is
anticipated to show significant growth through 2026. Booming medical
tourism industry offering advanced healthcare services at affordable costs
is the key factor driving the regional spine biologics market
- Some of the key
companies are Stryker; Orthofix International N.V.; K2M Inc.; Exactech
Inc.; Wright Medical Technology Inc.; DePuy Synthes Companies; Zimmer
Holding Inc.; Nuvasive Inc.; and Medtronic Inc. Strategic acquisitions and
presence of new entrants are making the market immensely competitive.
Browse request sample of this report by
Grand View Research: https://www.grandviewresearch.com/industry-analysis/spine-biologics-market/request/rs1
Grand
View Research has segmented the global spine biologics market report on the
basis of product, end use, and region:
Spine
Biologics Product Outlook (Revenue, USD Million, 2014 - 2026)
- Spinal Allografts
- Machined Bones
Allograft
- Demineralized Bone
Matrix
- Bone Graft
Substitutes
- Bone Morphogenetic
Proteins
- Synthetic Bone
Grafts
- Cell-based Matrix
Spine
Biologics End-use Outlook (Revenue, USD Million, 2014 - 2026)
- Hospitals
- Ambulatory Surgical
Centers
- Others
Spine
Biologics Regional Outlook (Revenue, USD Million, 2014 - 2026)
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Italy
- Spain
- Russia
- Asia Pacific
- Japan
- China
- India
- Australia
- Singapore
- South Korea
- Latin America
- Brazil
- Mexico
- Argentina
- Middle East &
Africa
- South Africa
- Saudi Arabia
- UAE
About Grand View Research
Grand View Research, Inc. is a U.S. based market
research and consulting company, registered in the State of California and
headquartered in San Francisco. The company provides syndicated research
reports, customized research reports, and consulting services. To help clients
make informed business decisions, we offer market intelligence studies ensuring
relevant and fact-based research across a range of industries, from technology
to chemicals, materials and healthcare.
For more info visit @ https://www.grandviewresearch.com
No comments:
Post a Comment